Note: Castle Creek Biosciences's revenues are gauged from an analysis of company filings.
Castle Creek Biosciences's Income Statement (based on Industry Averages)
Castle Creek Biosciences P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Investor Activity
Castle Creek Biosciences has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
May 2, 2022
54
100%
$113 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Castle Creek Biosciences is developing and marketing.
Castle Creek Biosciences doesn't have any recent trademark applications, indicating Castle Creek Biosciences is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
LENTI-VO Testing, inspection, research, and development of pharmaceutical preparations for in vivo cell therapy, in vivo gene therapy and gene editing; medical and scientific research in the fields of in vivo cell therapy, in vivo gene therapy and gene editing; pharmaceutical research services; pharmaceutical drug development services
05/10/2022
LENTI-VEX Testing, inspection, research, and development of pharmaceutical preparations for ex vivo cell therapy, ex vivo gene therapy and gene editing; medical and scientific research in the fields of ex vivo cell therapy, ex vivo gene therapy and gene editing; pharmaceutical research services; pharmaceutical drug development services
05/10/2022
D-FI Gene therapy products, namely, genetically modified cells for medical use for the treatment of dystrophic epidermolysis bullosa; pharmaceutical preparations and injectable biological preparations containing genetically modified materials for treatment of dystrophic epidermolysis bullosa; Pharmaceutical preparations and therapeutic preparations for treatment of skin diseases, connective tissue diseases, arthritis and autoimmune diseases
11/30/2021
See all trademarks and details in the Full Report.
Market Share of Castle Creek Biosciences's Largest Competitors
A competitive analysis shows these companies are in the same general field as Castle Creek Biosciences, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Castle Creek Biosciences.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
Future Competition: Castle Creek Biosciences's Fastest Growing Competitors
These companies are in the same general field as Castle Creek Biosciences and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.
My Watch List
